Basilea Pharmaceutica Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Basilea Pharmaceutica Limited with three other
miscellaneous service companies in Europe:
sales of 71.87 million Euros [US$83.67 million]
of which 72%
Oxford BioMedica plc
of UNITED KINGDOM
(£87.73 million [US$121.00 million]
of which 99%
was Platform), and
based in UNITED KINGDOM
(£86.39 million [US$119.16 million]
of which 64%
During the second
quarter of 2021, sales at Basilea Pharmaceutica Limited totalled
47.52 million Swiss Francs.
This is a drop of 23.6%
from the 62.17 million Swiss Francs in sales at the company during the second quarter in 2020.
Basilea Pharmaceutica Limited reported sales of 112.42 million Swiss Francs (US$122.33 million)
December of 2020.
decrease of 2.1%
versus 2019, when the company's sales were 114.79 million Swiss Francs.